Reference health

Neuroinflammation in mouse models of Alzheimer's disease

https://doi.org/10.1111/cen3.12475
CiteStamped reference-health badge
66/66 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 66 checked references that resolve
resolves10.15252/emmm.201606210
The amyloid hypothesis of Alzheimer's disease at 25 years
resolves10.1056/NEJMoa1202753
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
resolves10.1523/JNEUROSCI.3076-10.2011
<i>In Vivo</i>Positron Emission Tomographic Imaging of Glial Responses to Amyloid-β and Tau Pathologies in Mouse Models of Alzheimer's Disease and Related Disorders
resolves10.1016/j.ajpath.2011.05.047
Reactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer's Disease
resolves10.1007/s00401-016-1662-x
Alzheimer’s disease: experimental models and reality
resolves10.1016/S0197-4580(99)00065-2
Evidence for glial-mediated inflammation in aged APPSW transgenic mice
resolves10.1016/S0002-9440(10)63945-4
Aβ-Induced Inflammatory Processes in Microglia Cells of APP23 Transgenic Mice
resolves10.1038/nn.2858
Potent amyloidogenicity and pathogenicity of Aβ43
resolves10.1038/nn.3697
Single App knock-in mouse models of Alzheimer's disease
resolves10.1007/978-4-431-56068-5_50
Chronic Neuroinflammation Underlying Pathogenesis of Alzheimer’s Disease
resolves10.15252/embj.201797397
APP mouse models for Alzheimer's disease preclinical studies
resolves10.1523/JNEUROSCI.1907-16.2016
Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression
resolves10.1074/jbc.M117.811315
Endoplasmic reticulum stress responses in mouse models of Alzheimer's disease: Overexpression paradigm versus knockin paradigm
resolves10.1038/nn.4107
ScaleS: an optical clearing palette for biological imaging
resolves10.1523/JNEUROSCI.1034-15.2015
Neuronal Store-Operated Calcium Entry and Mushroom Spine Loss in Amyloid Precursor Protein Knock-In Mouse Model of Alzheimer's Disease
resolves10.1523/JNEUROSCI.1136-17.2017
Microglia-Mediated Synapse Loss in Alzheimer's Disease
resolves10.1016/S0896-6273(03)00434-3
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
resolves10.1038/s41598-017-17999-3
Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
resolves10.1186/s13024-017-0231-7
Practical considerations for choosing a mouse model of Alzheimer’s disease
resolves10.1111/nan.12213
Invited review: Frontotemporal dementia caused by <i>microtubule‐associated protein tau</i> gene (<scp><i>MAPT</i></scp>) mutations: a chameleon for neuropathology and neuroimaging
resolves10.3233/JAD-179933
Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy
resolves10.1016/j.neuron.2007.01.010
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
resolves10.1126/science.1058189
Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP
resolves10.1186/s12974-015-0291-y
Rodent models of neuroinflammation for Alzheimer’s disease
resolves10.1038/nrn2038
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
resolves10.1016/j.neuron.2013.12.034
Reactive Gliosis and the Multicellular Response to CNS Damage and Disease
resolves10.3389/fnins.2017.00680
Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
resolves10.1016/j.neuron.2018.01.031
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
resolves10.1097/MCO.0000000000000065
Cellular senescence and the senescent secretory phenotype in age-related chronic diseases
resolves10.1159/000353395
Effect of Proinflammatory Gene Polymorphisms on the Risk of Alzheimer's Disease
resolves10.1186/1742-2094-11-25
Modulation of inflammation in transgenic models of Alzheimer’s disease
resolves10.1038/nature11729
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
resolves10.1016/j.arr.2013.12.007
The role of inflammasome in Alzheimer's disease
resolves10.1038/nature25158
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
resolves10.1038/nn.2511
Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease
resolves10.1093/brain/awv081
Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain
resolves10.1038/nn.4132
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
resolves10.1097/NEN.0b013e3182933788
Differential Relationships of Reactive Astrocytes and Microglia to Fibrillar Amyloid Deposits in Alzheimer Disease
resolves10.1096/fj.12-208660
Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice
resolves10.15252/emmm.201708184
Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
resolves10.3389/fnagi.2016.00160
Mechanisms of Aβ Clearance and Degradation by Glial Cells
resolves10.1159/000490349
The Glymphatic System and Waste Clearance with Brain Aging: A Review
resolves10.1038/s41467-017-00037-1
Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway
resolves10.1002/glia.23270
Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease
resolves10.1038/nature21029
Neurotoxic reactive astrocytes are induced by activated microglia
resolves10.1038/s41591-018-0051-5
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
resolves10.1016/j.bj.2018.01.003
Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
resolves10.1212/WNL.47.2.425
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease
resolves10.1056/NEJMoa010178
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
resolves10.1007/s40266-015-0239-z
Non-Steroidal Anti-Inflammatory Drugs as a Treatment for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Treatment Effect
resolves10.1590/1980-57642016dn11-020002
Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease
resolves10.1016/j.bbcan.2017.07.001
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
resolves10.2174/1570159X15666170313122937
The Infectious Etiology of Alzheimer’s Disease
resolves10.1016/j.tins.2018.05.001
A Call for a Neuroscience Approach to Cancer-Related Cognitive Impairment
resolves10.1186/2049-9256-2-2
HIV-associated neurocognitive disorders
resolves10.1371/journal.pone.0010830
T Cells Specifically Targeted to Amyloid Plaques Enhance Plaque Clearance in a Mouse Model of Alzheimer's Disease
resolves10.4049/jimmunol.1200947
IFN-γ Production by Amyloid β–Specific Th1 Cells Promotes Microglial Activation and Increases Plaque Burden in a Mouse Model of Alzheimer’s Disease
resolves10.1371/journal.pone.0066664
Enhanced Chemokine Receptor Expression on Leukocytes of Patients with Alzheimer's Disease
resolves10.1016/j.cell.2013.11.024
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
resolves10.1172/JCI76304
Gut/brain axis and the microbiota
resolves10.1038/nature12331
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
resolves10.1016/j.coph.2017.10.005
Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions
resolves10.3389/fmicb.2018.00737
Circadian Disruption Changes Gut Microbiome Taxa and Functional Gene Composition
resolves10.1016/bs.irn.2016.07.003
Sleep and Microbes
resolves10.15280/jlm.2018.8.1.1
Influence of Altered Gut Microbiota Composition on Aging and Aging-Related Diseases
resolves10.1111/cen3.12308
<i>In vivo</i> imaging of neuroinflammation in Alzheimer's disease
The 4 references without a DOI — listed, not checked
no DOI — not checkedActivation and regulation of the inflammasomes
no DOI — not checkedNeuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors
no DOI — not checkedAlzheimer's disease and osteoporosis
no DOI — not checkedStress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1111/cen3.12475"><img src="https://citestamp.com/citestamped/10.1111/cen3.12475/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1111/cen3.12475/badge.svg)](https://citestamp.com/citestamped/10.1111/cen3.12475)